Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
gene therapy
life sciences
national blog main
national top stories
zolgensma
4
×
biotech
clinical trials
deals
new york top stories
novartis
spinal muscular atrophy
boston blog main
boston top stories
fda
hemophilia
medicaid
national
new york blog main
roche
san francisco top stories
spark therapeutics
achromatopsia
acquisitions
adeno-associated virus
advanced therapies
alexandria venture investments
altitude life science ventures
american society of gene and cell therapy
arch venture partners
atmp
avexis
beta-thalassemia
bill cassidy
billy dunn
biogen
bioprocess insider
bluebird bio
bms
boxer capital
brammer bio
What
therapy
4
×
gene
medicine
access
advanced
age
approved
atrophy
bigger
biggest
capacity
car
cell
come
consolidation
crispr
crude
cutting
daily
deal
despite
drug
edge
effects
emerging
encoded
evrysdi
falcon
fda
focus
friday
gave
green
help
home
illumina’s
intended
j
johnson
lasting
Language
unset
Current search:
zolgensma
×
therapy
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy